Polyestradiol Phosphate

聚磷酸雌二醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePolyestradiol Phosphate
Drug Alias NamePolyestradioli phosphas聚雌二醇磷酸酯磷酸聚雌二醇EstradurinEstradurine +[6] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth-Ayerst
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeL02AA02
Related LinksWikipediaKEGG